search for




 

Current Status of Adverse Drug Reaction Relief System in Korea, Japan and Taiwan
Yakhak Hoeji 2019;63(4):214-220
Published online August 31, 2019
© 2019 The Pharmaceutical Society of Korea.

Sang-Wan An, Yunha Noh, Yeon-Hee Baek, Han-Heui Park, So-Hee Park, Sungmin Park, and Ju-Young Shin#

School of Pharmacy, Sungkyunkwan University
Correspondence to: #Ju-Young Shin, School of Pharmacy, Sungkyunkwan University, 2066, Jangan-gu, Suwon-si, Gyeonggi-do, South Korea Tel: +82-31-290-7702, Fax: +82-31-290-8800 E-mail: shin.jy@skku.edu

These authors contributed equally to this work.
Received May 10, 2019; Revised July 31, 2019; Accepted August 5, 2019.
Abstract
The adverse drug reaction relief system is no-fault compensation system which provides compensation for severe injuries that were caused by adverse reaction even after proper use of medicines. The purpose of this study is to evaluate current status of the adverse drug reaction relief system in Japan, Taiwan, and Korea. We investigated the relief system in above three countries through websites, literatures, reports, spot investigation and e-mail questionnaires. Although great similarities for the relief system were recognized among the three countries, the difference among the countries and the unique characteristics of each country’s relief system was also identified; for example, the relief for injuries by off-label uses, details of relief benefits, the relief payment for the adverse drug reactions, and the compensation for medical expenses which is classified as non-reimbursement treatment. Therefore, it is possible to establish more valuable no-fault compensation system in Korea through application of advantage and experience for the relief system in Japan and Taiwan.
Keywords : adverse drug reaction relief system, no-fault compensation, drug injury, non-reimbursement treatment, off-label use


August 2019, 63 (4)
Full Text(PDF) Free

Social Network Service
Services

Cited By Articles
  • CrossRef (0)